Oct 20, 2026 06:33AM
Oct 19, 2026 05:31AM
Oct 12, 2026 06:05AM
Oct 6, 2026 06:32AM
Sep 23, 2026 08:14AM
Jun 23, 2026 08:31AM
Jun 18, 2026 08:31AM Quoin Pharma forms Japan subsidiary to advance QRX003 commercialization
Jun 16, 2026 08:31AM
Jun 4, 2026 08:31AM
Jun 2, 2026 08:31AM
May 4, 2026 06:08AM
Apr 28, 2026 08:32AM
Mar 11, 2026 08:30AM
Jan 27, 2026 08:31AM Quoin seeks orphan drug status for QRX003 in Japan
Nov 11, 2025 08:31AM
Oct 28, 2025 08:31AM
Oct 21, 2025 08:30AM
Aug 7, 2025 09:40AM
Jul 29, 2025 08:30AM
Jun 24, 2025 08:34AM
May 22, 2025 07:31AM Quoin Pharmaceuticals Ltd (QNRX) Announces FDA Clearance to Initiate Second Pivotal Whole Body QRX003 Netherton Syndrome Clinical Study
May 14, 2025 07:30AM
Apr 30, 2025 07:31AM
Mar 25, 2025 07:31AM
Mar 4, 2025 07:30AM
Feb 27, 2025 07:31AM
Jan 23, 2025 05:30AM
Jan 14, 2025 08:34AM Quoin Pharmaceuticals (QNRX) Announces Further Positive Clinical Data from Ongoing Pediatric Netherton Syndrome Study
Jan 6, 2025 08:33AM
Dec 20, 2024 09:20AM
Dec 18, 2024 08:18AM
Nov 5, 2024 08:02AM
Oct 22, 2024 08:01AM
Sep 9, 2024 08:33AM
Jun 12, 2024 08:14AM Quoin Pharmaceuticals (QNRX) Announces Signing of Research Agreement with University College Cork, Ireland

470,321 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All